Future Trends in Cancer Prevention and Interception in Cancer Predisposition Syndromes: Leveraging Insights From High-Risk Populations.
Blood tests may detect cancer before imaging in high-risk families, while vaccines and common drugs show promise for preventing cancer in genetically vulnerable populations.
Liquid biopsy can detect malignancies before radiologic findings in CPS patients; immunoprevention neoantigen vaccines in MMR-deficient tumors show preliminary immunogenicity; metformin in Li-Fraumeni and aspirin in Lynch syndrome demonstrate cancer risk modification in clinical studies. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- Narrative review with synthesis of RCTs, population studies, and phase I/II trial data
- Category
- early_cancer_detection_liquid_biopsy
- Maturity
- Exploratory
- Journal
- International Journal of Cancer
Why it surfaced
Directly relevant to liquid biopsy and early cancer detection watchlist; covers actionable interception strategies across Li-Fraumeni, Lynch, and other major CPS; high-impact International Journal of Cancer publication.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.